BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Microsoft
MSFT
|
+$962M |
| 2 |
Amazon
AMZN
|
+$682M |
| 3 |
Apple
AAPL
|
+$231M |
| 4 |
iShares MSCI Japan ETF
EWJ
|
+$200M |
| 5 |
Broadcom
AVGO
|
+$172M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.19B |
| 2 |
SPDR S&P Biotech ETF
XBI
|
+$457M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$421M |
| 4 |
Motorola Solutions
MSI
|
+$353M |
| 5 |
Industrial Select Sector SPDR Fund
XLI
|
+$323M |
Sector Composition
| 1 | Technology | 22.57% |
| 2 | Consumer Discretionary | 10.5% |
| 3 | Financials | 9.56% |
| 4 | Healthcare | 8.43% |
| 5 | Communication Services | 6.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Citius Pharmaceuticals
CTXR
$20.6M
| $68.4K | ﹤0.01% |
1,777
+685
| +63% | +$26.4K |
|
|
USX
2902
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $68K | ﹤0.01% |
11,586
+3,782
| +48% | +$22.2K |
|
2903
Kopin
KOPN
$344M
| $67.9K | ﹤0.01% |
16,605
+2,666
| +19% | +$10.9K |
|
2904
CorMedix
CRMD
$955M
| $66.6K | ﹤0.01% |
14,646
+5,580
| +62% | +$25.4K |
|
2905
Silicom
SILC
$101M
| $66K | ﹤0.01% |
+1,279
| New | +$66K |
|
2906
Legacy Housing
LEGH
$646M
| $65.9K | ﹤0.01% |
2,491
+518
| +26% | +$13.7K |
|
2907
Brookfield
BN
$100B
| $65.3K | ﹤0.01% |
1,337
-3,855
| -74% | -$188K |
|
2908
Willis Lease Finance
WLFC
$1.13B
| $65.1K | ﹤0.01% |
1,728
+821
| +91% | +$30.9K |
|
2909
Tenaris
TS
$18.5B
| $64.9K | ﹤0.01% |
3,109
+200
| +7% | +$4.17K |
|
2910
CRH
CRH
$74.7B
| $64.7K | ﹤0.01% |
+1,226
| New | +$64.7K |
|
2911
Canadian National Railway
CNI
$57.7B
| $63.5K | ﹤0.01% |
517
+516
| +51,600% | +$63.4K |
|
2912
KalVista Pharmaceuticals
KALV
$775M
| $63.1K | ﹤0.01% |
4,772
+1,173
| +33% | +$15.5K |
|
|
AERI
2913
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $63.1K | ﹤0.01% |
8,992
+1,401
| +18% | +$9.84K |
|
2914
Liquidia Corp
LQDA
$2.35B
| $62.2K | ﹤0.01% |
12,771
+12,485
| +4,365% | +$60.8K |
|
2915
Aquestive Therapeutics
AQST
$590M
| $62K | ﹤0.01% |
15,950
+15,833
| +13,532% | +$61.6K |
|
2916
iShares MSCI Global Gold Miners ETF
RING
$2.1B
| $61.7K | ﹤0.01% |
+2,289
| New | +$61.7K |
|
2917
KVH Industries
KVHI
$114M
| $61.6K | ﹤0.01% |
6,700
+2,556
| +62% | +$23.5K |
|
|
DS
2918
DELISTED
Drive Shack Inc.
DS
| $61.5K | ﹤0.01% |
42,979
+22,898
| +114% | +$32.7K |
|
2919
Criteo
CRTO
$1.18B
| $60.9K | ﹤0.01% |
1,567
-293
| -16% | -$11.4K |
|
2920
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$9.84B
| $60.7K | ﹤0.01% |
+453
| New | +$60.7K |
|
2921
Invesco DB Commodity Index Tracking Fund
DBC
$1.28B
| $60K | ﹤0.01% |
2,889
-133
| -4% | -$2.76K |
|
|
CLVS
2922
DELISTED
Clovis Oncology, Inc.
CLVS
| $59.6K | ﹤0.01% |
21,996
+2,287
| +12% | +$6.2K |
|
2923
Xoma
XOMA
$442M
| $59.6K | ﹤0.01% |
2,858
+1,422
| +99% | +$29.6K |
|
2924
United States Lime & Minerals
USLM
$3.56B
| $59K | ﹤0.01% |
2,285
+450
| +25% | +$11.6K |
|
2925
CoreCard
CCRD
$208M
| $58.7K | ﹤0.01% |
1,513
+314
| +26% | +$12.2K |
|